Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency

Cardiology

Volumn 108, Issue 3, 2007, Pages 193-199

  Tessone, Ariel ^a   Gottlieb, Shmuel ^a   Barbash, Israel M ^a   Garty, Moshe ^a   Porath, Avi ^a   Tenenbaum, Alexander ^a   Hod, Hanoch ^a   Boyko, Valentina ^a   Mandelzweig, Lori ^a   Behar, Solomon ^a   Leor, Jonathan ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Acute myocardial infarction; Heart failure; Renal insufficiency

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIAC PATIENT; CARDIOGENIC SHOCK; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONFIDENCE INTERVAL; DEATH; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; SEPSIS; STANDARD; STROKE;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTILIPEMIC AGENTS; ASPIRIN; CREATININE; DRUG UTILIZATION; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT CARE; TREATMENT OUTCOME;

EID: 34948904869     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096777     Document Type: Article

References (24)

1. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-1295.
2. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002;137:563-570.
3. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002;137:555-562.
4. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction;A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44:E1-E211.
5. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, McCullough PA: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001;37:1191-1200.
6. O'Hanlon R, Reddan DN: Treatment of acute coronary syndromes in patients who have chronic kidney disease. Med Clin North Am 2005;89:563-585.
7. Reddan DN, Szczech L, Bhapkar MV, Moliterno DJ, Califf RM, Ohman EM, Berger PB, Hochman JS, Van de Werf F, Harrington RA, Newby LK: Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial Transplant 2005;20:2105-2112.
8. Behar S, Battler A, Porath A, Leor J, Grossman E, Hasin Y, Mittelman M, Feigenberg Z, Rahima-Maoz C, Green M, Caspi A, Rabinowitz B, Garty M: A prospective national survey of management and clinical outcome of acute myocardial infarction in Israel, 2000. Isr Med Assoc J 2003;5:249-254.
9. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 1998;32:992-999.
10. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
11. Shlipak MG, Browner WS, Noguchi H, Massie B, Frances CD, McClellan M: Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am J Med 2001;110:425-433.
12. Frances CD, Noguchi H, Massie BM, Browner WS, McClellan M: Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function. Arch Intern Med 2000;160:2645-2650.
13. Berger AK, Duval S, Krumholz HM: Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003;42:201-208.
14. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ: Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 2002;144:226-232.
15. Dragu R, Behar S, Sandach A, Boyko V, Kapeliovich M, Rispler S, Hammerman H: Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? Am J Cardiol 2006;97:1142-1145.
16. Leor J, Goldbourt U, Behar S, Boyko V, Reicher-Reiss H, Kaplinsky E, Rabinowitz B: Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiovasc Drugs Ther 1995;9:609-617.
17. Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L, Kaplinsky E: Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med 1993;153:345-353.
18. Silverberg D, Wexler D, Blum M, Schwartz D, Iaina A: The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens 2004;13:163-170.
19. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM: Renal impairment and outcomes in heart failure: systematic review and metaanalysis. J Am Coll Cardiol 2006;47:1987-1996.
20. Stevens LA, Levey AS: Measurement of kidney function. Med Clin North Am 2005;89:457-473.
21. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-2483.
22. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL: N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-2782.
23. Goldberg A, Hammerman H, Petcherski S, Zdorovyak A, Yalonetsky S, Kapeliovich M, Agmon Y, Markiewicz W, Aronson D: Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 2005;150:330-337.
24. Walsh CR, O'Donnell CJ, Camargo CA Jr, Giugliano RP, Lloyd-Jones DM: Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 2002;144:1003-1011.